Faslo Tech 250mg - Fulvestrant Injection

Name: Faslo Tech 250mg - Fulvestrant Injection
Brand: NEXT GEN BIOTECH
Price: 15000.0 INR
Availability: InStock

Price 15000.0 INR/ Box

Get a Price/Quote

MOQ : 1 Box

Faslo Tech 250mg - Fulvestrant Injection Specification

Indication
For Intra-muscular use only; Used in the treatment of hormone receptor positive metastatic breast cancer

Dosage Form
Injection (Pre-filled Syringe)

Salt Composition
Fulvestrant Injection

Feature
Ready-to-use, single-use prefilled syringe, for intra-muscular administration, hospital/clinical use only, prescription required

Ingredients
Fulvestrant

Application
Medical, Oncology - Breast Cancer Therapy

Physical Color/Texture
Clear solution, presented in a pre-filled syringe

Storage Instructions
Store below 25C, protect from light, do not freeze

Shelf Life
As mentioned on packaging (typically 24-36 months from date of manufacture)

Strength
250mg per 5ml syringe

Packaging Type
Box with pre-filled syringe

Prescription Status
Rx (Prescription only)

Patient Advisory
For single use only; administered by healthcare professional

Marketed By
FASLOTECH

Administration Route
Intra-muscular

Volume per Syringe
5 ml

About Faslo Tech 250mg - Fulvestrant Injection

Background and Date of approval FULVESTRANT

Fulvestrant is an anticancer medication that was approved for its medical use on 25th April 2002.

Uses of FULVESTRANT

Fulvestrant Injection has been developed to treat advanced and metastatic breast cancer in men and menopausal women who have stopped responding to other treatments.

How is FULVESTRANT administered?

Fulvestrant is available as a 5ml prefilled syringe in doses 50mg and 250mg. The recommended dosage is 500 mg as two 5ml injections on the 1st, 15th, and 29th days and once a month thereafter. For patients with liver problems, the recommended dose is 250mg. Your physician will administer this medicine intramuscularly into the buttocks.

Side Effects of FULVESTRANT

The common side effects that are likely to occur while you are on the treatment with Fulvestrant Injection are injection site pain, nausea, muscle, joint, and bone pain, headache, back pain, tiredness, pain in the arms, hands, legs, or feet, hot flashes, cough, vomiting, loss of appetite, weakness, shortness of breath, constipation, increased liver enzymes, and diarrhea. Fulvestrant Injection may also cause injection site-related nerve damage. Call your healthcare provider if you experience numbness, tingling, or weakness after taking this injection.

Highly Effective Oncology Therapy

Faslo Tech 250mg Fulvestrant Injection offers a targeted solution for hormone receptor-positive metastatic breast cancer. By administering Fulvestrant directly into the muscle, it efficiently supports cancer care regimens, ensuring reliable absorption and effectiveness for eligible patients in a clinical environment.

Simple and Safe Administration

The pre-filled syringe makes Faslo Tech convenient for healthcare professionals, eliminating the need for mixing or preparation. Designed for single-use, it enhances safety by reducing contamination risk and ensures ease of use for both staff and patients undergoing cancer therapy.

Storage and Handling Instructions

To preserve the stability of Faslo Tech, it must be kept below 25C, away from direct light, and never frozen. Shelf life is typically 24-36 months from the manufacturing date; always check the packaging for specifics before use to ensure optimal efficacy.

FAQ's of Faslo Tech 250mg - Fulvestrant Injection:

Q: How should Faslo Tech 250mg Fulvestrant Injection be administered?

A: Faslo Tech 250mg should be administered by a healthcare professional as an intramuscular injection, typically in a hospital or clinical environment. The entire 5ml pre-filled syringe is intended for single use only.

Q: What are the main benefits of using Faslo Tech 250mg in breast cancer therapy?

A: Faslo Tech 250mg provides a reliable treatment option for hormone receptor-positive metastatic breast cancer with a ready-to-use pre-filled syringe, helping to simplify the administration process and reduce the risk of dosing errors or contamination.

Q: When is Faslo Tech 250mg indicated for patient use?

A: This injection is indicated for patients with hormone receptor-positive metastatic breast cancer, under guidance and prescription from an oncologist or qualified healthcare provider.

Q: Where should Faslo Tech 250mg be stored until use?

A: Faslo Tech 250mg must be stored below 25C, protected from light, and it should not be frozen. Proper storage helps maintain the integrity and safety of the medication.

Q: What is the process for using Faslo Tech 250mg Fulvestrant Injection?

A: A healthcare provider will remove the pre-filled syringe from its packaging, inspect it for clarity, and inject the full 5ml dose intramuscularly, typically into the buttock muscle, in accordance with prescribed protocols.

Q: Who can administer Faslo Tech 250mg, and is a prescription necessary?

A: Only licensed healthcare professionals should administer Faslo Tech 250mg, and it is available strictly by prescription to ensure proper patient monitoring and safety throughout treatment.

Tell us about your requirement